Victory Capital Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Victory Capital Management’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-29	Closed	-$2K	–	3187
2020 Q1	$2K	Buy	+29	New	+$2.92K	﹤0.01%	3676
2019 Q4	–	Sell	-11	Closed	-$1K	–	3198
2019 Q3	$1K	Buy	+11	New	+$1.42K	﹤0.01%	3717

Other funds holding SNOA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Victory Capital Management's SNOA Position: Q2 2020 in Review

Victory Capital Management sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2020, closing a stake of 29 shares — an estimated $2K sold.

Victory Capital Management first reported a position in SNOA in Q3 2019 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 13 funds tracked by Wall St. Rank hold SNOA as of Q2 2020.

Victory Capital Management reported no remaining Sonoma Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Victory Capital Management sold 29 Sonoma Pharmaceuticals shares in Q2 2020, an estimated $2K.
Victory Capital Management first reported a position in Sonoma Pharmaceuticals in Q3 2019 and held it in 2 quarters.
Victory Capital Management's Sonoma Pharmaceuticals position peaked at $2K in Q1 2020.
13 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.